US, UK approve gene editing therapy to treat inherited blood disease, sickle cell disease
SYDNEY, Dec.18 (PTI): A new gene therapy has just been approved as a treatment for the inherited blood disease, sickle cell disease, in the UK and the US. What makes this therapy unique is that it uses a gene-editing technology known as CRISPR, which allows for precise and efficient editing of the genetic code. But this doesn’t mean human gene modification is about to go viral. Rather, this is a safe and sensible technology that has the power to help the 3,00,000 babies born with sickle cell disease each year and the nearly 10 million people estimated to suffer from